Jones Financial Companies
RPRX icon

Jones Financial Companies’s Royalty Pharma RPRX Stock Holding History

Jones Financial Companies’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$705K Buy
12,546
+1,203
+11% +$62.6K ﹤0.01% 2056
2026
Q1 		$526K Buy
11,343
+1,527
+16% +$66.9K ﹤0.01% 2023
2025
Q4 		$379K Buy
9,816
+48
+0.5% +$1.83K ﹤0.01% 1624
2025
Q3 		$342K Buy
9,768
+811
+9% +$29.4K ﹤0.01% 1564
2025
Q2 		$321K Buy
8,957
+758
+9% +$25.1K ﹤0.01% 1459
2025
Q1 		$257K Buy
8,199
+1,243
+18% +$39.4K ﹤0.01% 1390
2024
Q4 		$177K Sell
6,956
-730
-9% -$19.4K ﹤0.01% 1406
2024
Q3 		$217K Buy
7,686
+2,689
+54% +$74.5K ﹤0.01% 1104
2024
Q2 		$132K Buy
+4,997
New +$139K ﹤0.01% 953

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's RPRX Position: Q2 2026 in Review

Jones Financial Companies increased its Royalty Pharma (RPRX) stake by 11% in Q2 2026, buying an estimated $62.6K and bringing the position to 12,546 shares worth $705K. The position accounts for ﹤0.01% of the portfolio, ranked #2056.

Jones Financial Companies first reported a position in RPRX in Q2 2024 and has held it in 9 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Jones Financial Companies held 12,546 shares of Royalty Pharma worth $705K as of Q2 2026.
  • Jones Financial Companies bought 1,203 Royalty Pharma shares in Q2 2026, an estimated $62.6K.
  • Royalty Pharma made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2056 holding.
  • Jones Financial Companies first reported a position in Royalty Pharma in Q2 2024 and has held it in 9 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.